VitalSigns
Med-Sci Matters by Dr. Dave

Med-Sci Matters by Dr. Dave

This edition of Med-Sci Matters includes recent promising findings with type 1 diabetes, heart disease, cancer and human “healthspan”; the cost-benefit battle with a PCSK9 inhibitor; questions about the rigor of FDA accelerated approvals; and – not for geeks only!... Read More

September 6, 2017 0 Comments
Dr. Dave’s Med-Sci Matters

February 20, 2017

0 Comments

Categories: Global Healthcare, Health and Wellness, Healthcare

Dr. Dave’s Med-Sci Matters

Written by

Genetically altering humans? Maybe we Khan! While advances in gene therapy research continue to accelerate, an enduring redline has been the germline – no tinkering with the DNA of a human embryo, egg or sperm. Doing so would mean not...

The Week That Was: Crises in Communications

February 20, 2017

0 Comments

Categories: FDA News, Healthcare, The Week That Was

The Week That Was: Crises in Communications

Written by

Whether your cultural point of reference is Jay-Z or Annie!, we can all agree that last week was a “hard knock life” for orphans…orphan drugs, that is. We saw Marathon hit pause on its launch of Emflaza, the steroid approved...

Dr. Lizzie’s Med-Sci Matters

February 15, 2017

0 Comments

Categories: Communications, Global Healthcare, Health and Wellness

Dr. Lizzie’s Med-Sci Matters

Written by

Mind-reading device shows “locked-in” patients are happy and offers way to communicate A non-invasive device has been developed that can detect yes/no answers in people who are completely paralyzed but otherwise healthy with normal cognitive function (“locked-in syndrome”). The Swiss...

The Week That Was: Crises in Healthcare Communications

February 13, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Healthcare Communications

Written by

Brrrrrrr… If you’re one of our East Coast readers, we shivered with you through a blizzard and this icy weekend. We wish we had some news to warm your heart and ease you into a tranquil week. But, no such...

Dr. Dave’s Med-Sci Matters

February 7, 2017

0 Comments

Categories: Global Healthcare, Healthcare

Dr. Dave’s Med-Sci Matters

Written by

PCSK9 inhibitors (evolocumab and alirocumab) have been approved based primarily on studies showing they reduce LDL cholesterol (the “bad” cholesterol) and atherosclerotic plaque in patients with high LDLs and already taking statins. However, treaters and payors have been waiting for...

The Week That Was: Crises in Communications

February 6, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

Grab your foam fingers and jerseys, people: it’s The Week That Was Super Bowl edition! Check out these stories taking the field this week: There was a major huddle at the White House between two previously opposing teams: POTUS and...

Survey Says: Surveys are Worth It

January 31, 2017

0 Comments

Categories: Communications, Healthcare, Measurement, PR Research

Survey Says: Surveys are Worth It

Written by

Surveys have been a longstanding staple tactic for healthcare communications professionals, valued for laying the foundation for rich content and insights that can help generate media storylines. They can also be a large research investment, and within a content cluttered...

The Week That Was: Crises in Communications

January 31, 2017

0 Comments

Categories: The Week That Was

The Week That Was: Crises in Communications

Written by

Talk about a dull week…NOT! As we see a number of sweeping actions out of Washington, your friends at inVentiv’s Issues Management Practice are here to cover the issues that matter! This week we ask why the White House Press...

An Advocacy Rx for Progress in Mental Health

January 18, 2017

0 Comments

Categories: Advocacy

An Advocacy Rx for Progress in Mental Health

Written by

As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis. Fortunately, there’s an abundance of smart thinking on how to improve...

Dr. Dave’s Med-Sci Matters

January 11, 2017

0 Comments

Categories: Communications, FDA News, Health, Healthcare, Medical Devices and Diagnostics

Dr. Dave’s Med-Sci Matters

Written by

Oh nuts! It was hard to miss the coverage this week of new guidelines from the National Institute of Allergies and Disease (NIAID) – published January 5 in J Allergy Clin Immunol – suggesting that early introduction of peanuts into...